News

Sun Pharma’s alfuzosin hydrochloride extended release tablets are the generic version of Sanofi-aventis’ Uroxatral extended release tablets. Uroxatral is approved to treat signs and symptoms of benign prostatic

Under the agreement, Lonza is responsible to produce materials for Phase 2 trial at its mammalian development and manufacturing plant. IMMUNE claims its human immunoglobulin monoclonal antibody Bertilimumab

The trial aims to evaluate the tolerability, pharmacokinetics (PK) and safety of GLPG0492 on muscle function in healthy volunteers. Earlier, in a Phase I study in healthy volunteers,

Rib-X’s RX-04 program employs a proprietary approach for rational drug design resulting in entirely novel classes of compounds. Recently presented data confirmed the new compounds directly impact ribosome

P2D Bioscience has received a sum of $32,000 for establishing the efficacy of these drugs. The second phase of these studies will investigate the safety and pharmacokinetics of

As per the original agreement, Teva is responsible for marketing and distributing Multikine in Israel and Turkey, while the extended agreement allows Teva to include Croatia and Serbia.

Provantis is a modern, fully integrated Windows-based system for organizations and universities engaged in non-clinical evaluation studies. The submit solution suite converts data from any source system into

Robinson Pharma can now use the USP Verified Mark (DSVP) on its product labels, nutraingredients-usa.com reported. The approval has been granted for glucosamine-based joint health formulations which include

The launching of the drug is backed by the Japanese Ministry of Health, Labor and Welfare’s (MHLW) approval for edoxaban 15mg and 30mg tablets in April 2011. The